| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/14/2006 | US20060204482 Methods of islet isolation and transplantation |
| 09/14/2006 | US20060204479 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 09/14/2006 | CA2614734A1 Microencapsulated compositions for endoluminal tissue engineering |
| 09/14/2006 | CA2603711A1 Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof |
| 09/14/2006 | CA2601550A1 Method of in-vitro diagnosis of alzheimer's disease by means of a monoclonal antibody |
| 09/14/2006 | CA2600951A1 Growth factor mutants with improved biological activity |
| 09/14/2006 | CA2599577A1 Nucleic acids and proteins and methods for making and using them |
| 09/13/2006 | EP1700921A2 Regulation of a human asparagine-hydroxylase |
| 09/13/2006 | EP1700913A1 Fluorescent proteins |
| 09/13/2006 | EP1700868A2 A method for removing an antibody from blood or plasma |
| 09/13/2006 | EP1700867A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/13/2006 | EP1700605A2 Lyophilized methionine-containing protein preparations stabilized over long time |
| 09/13/2006 | EP1700603A2 Immunostimulatory nucleic acids |
| 09/13/2006 | EP1700123A2 Method for enhancing transport of semiconductor nanocrystals across biological membranes |
| 09/13/2006 | EP1700119A1 Beta-lactamase cd4+ t-cell epitopes |
| 09/13/2006 | EP1699927A1 Fatty acid elongase (fae) genes and their utility in increasing erucic acid and other very long-chain fatty acid proportions in seed oil |
| 09/13/2006 | EP1699918A1 High-titer retroviral packaging cells |
| 09/13/2006 | EP1699917A2 Stem cell targeting using magnetic particles |
| 09/13/2006 | EP1699916A1 Process for recycling solid supports for cultivation of anchorage-dependent cells |
| 09/13/2006 | EP1699915A1 Tissue regeneration method |
| 09/13/2006 | EP1699825A2 Methods for identifying functional antibodies |
| 09/13/2006 | EP1699824A2 Ztnf 12, a tumor necrosis factor |
| 09/13/2006 | EP1699822A2 Il-7 fusion proteins with antibody portions, their preparation and their use |
| 09/13/2006 | EP1699817A1 Avidin mutants |
| 09/13/2006 | EP1699523A2 Creation of a biological atrioventricular bypass to compensate for atrioventricular block |
| 09/13/2006 | EP1699486A2 Anti-human lymphotoxin alpha antibodies, compositions, methods and uses |
| 09/13/2006 | EP1699485A2 Anti-hydroxylase antibodies and uses thereof |
| 09/13/2006 | EP1699480A1 Allogeneic tumor therapeutic agent |
| 09/13/2006 | EP1699476A1 Method for preventing and treating diabetes using dg119 |
| 09/13/2006 | EP1699469A2 Recombinant factor viii having increased specific activity |
| 09/13/2006 | EP1699398A2 Enhancement of immune responses |
| 09/13/2006 | EP1699288A1 Method of ex vitro sowing, germination, growth and conversion of plant somatic embryos or germinants, and nutrient medium used therefor |
| 09/13/2006 | EP1649010A4 Novel nucleic acids from sesame plants |
| 09/13/2006 | EP1623018A4 Mptens as modifiers of the pten/igf pathway and methods of use |
| 09/13/2006 | EP1543111A4 Neurogenesis from hepatic stem cells |
| 09/13/2006 | EP1506027B1 Cell delivery fluid for prevention of cell settling in delivery system |
| 09/13/2006 | EP1499180A4 Cancer models |
| 09/13/2006 | EP1482871A4 Artificial vessel scaffold and artificial organs therefrom |
| 09/13/2006 | EP1363944B1 High-affinity antagonists of elr-cxc chemokines |
| 09/13/2006 | EP1339840B1 Schizophrenia-related voltage-gated ion channel gene and protein |
| 09/13/2006 | EP1312677B1 Nucleic acids encoding lettuce big-vein virus proteins and utilization thereof |
| 09/13/2006 | EP1311693B1 Transcription factor stress-related protein and methods of use in plants |
| 09/13/2006 | EP1306434B1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin |
| 09/13/2006 | EP1302477B1 Peptide fructose and complex thereof with binding protein |
| 09/13/2006 | EP1280828B1 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses |
| 09/13/2006 | EP1224288B1 Processed human chemokine phc-1 |
| 09/13/2006 | EP1196579B1 Tryptase inhibitor |
| 09/13/2006 | EP1163272B1 Antibodies specific for cyp1b1 |
| 09/13/2006 | EP1088084B1 Erythropoietin analog-human serum albumin fusion protein |
| 09/13/2006 | EP0843732B1 Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
| 09/13/2006 | EP0832192B1 Cryopreserved hepatocytes and process for doing same |
| 09/13/2006 | EP0755446B1 Cardiotrophin and uses therefor |
| 09/13/2006 | CN1833027A Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 09/13/2006 | CN1833026A Plant producing hyaluronic acid |
| 09/13/2006 | CN1833024A Nucleic acid construct containing hepatitis c virus (hcv) of genocype 2a genome-origin nucleic acid and cell having the nucleic acid construct transferred thereinto |
| 09/13/2006 | CN1833022A Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequence and their therapeutic use |
| 09/13/2006 | CN1833021A Oligodendrocyte precursor cells and method of obtaining and culturing the same |
| 09/13/2006 | CN1833020A Pro104 antibody compositions and methods of use |
| 09/13/2006 | CN1832964A Method of detecting probnp with a monoclonal antibody binding to the amino acids 41-46 |
| 09/13/2006 | CN1832960A Immunomodulating compositions, uses therefor and processes for their production |
| 09/13/2006 | CN1831121A Method for structuring hybridoma cell system for anti-human monoclonal antibody of hepatitis B virus and its application |
| 09/13/2006 | CN1831120A Hybridoma cell strain, and anti-human heparin enzyme monoclonal anti-body produced by it |
| 09/13/2006 | CN1831119A Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 09/13/2006 | CN1831118A Method for high efficiency and quick separation of hair papilla cells of human epicranium |
| 09/13/2006 | CN1831117A Cellula funeral and interment card, and its prepn. method |
| 09/13/2006 | CN1830243A Culturing method of wilsonii withont adding plant hormone |
| 09/13/2006 | CN1274828C Mouse derived EPOR outer cell region and human NOK intracell region infused acceptor and coding gene and uses |
| 09/13/2006 | CN1274827C Cancer gene and its coded protein and special cell line |
| 09/13/2006 | CN1274817C Anti prourokinase monoclonal antibody hybrid oma cell line and its application |
| 09/13/2006 | CN1274816C Molecular breeding method for quickly obtaining great amount of new transgenic plant varieties |
| 09/13/2006 | CN1274815C Neurocyte extract and its uses in mesenchyma stem cell differentiation induction |
| 09/13/2006 | CN1274814C Method for raising efficiency for producing transgenic animal |
| 09/13/2006 | CN1274813C Method for constructing suspension cell culture system for breeding broomrape callus |
| 09/12/2006 | US7105729 Cotton cultivar 00S07 |
| 09/12/2006 | US7105728 Plants exhibit male sterility, herbicide resistance, insect resistance, modified fatty acid metabolism, decreased phylate content, modified carbohydrate metabolism and resistance to bacterial disease, fungal disease or viral disease |
| 09/12/2006 | US7105727 Soybean cultivar S050164 |
| 09/12/2006 | US7105726 Plants exhibit male sterility, herbicide resistance, insect resistance, modified fatty acid metabolism, decreased phylate content, modified carbohydrate metabolism and resistance to bacterial disease, fungal disease or viral disease |
| 09/12/2006 | US7105653 Polypeptide comprising human interleukin-2 mutein with amino acid substitutions; , activates T cells over Natural Killer Cells; reduced toxicity; vectors, transformed host cells |
| 09/12/2006 | US7105652 Human tumor suppressor gene |
| 09/12/2006 | US7105651 Nucleotide sequences coding polypeptide for use in the treatment of cancer, inflammation and infection; for use as pesticide and antibiotic |
| 09/12/2006 | US7105650 Nucleotide sequences which code binding protein for use in taste simulation and food processing |
| 09/12/2006 | US7105649 Gene and amplification with polynucleotides having amino acid sequence |
| 09/12/2006 | US7105644 Secreted protein HHTLF25 antibodies |
| 09/12/2006 | US7105643 Antibodies for immunoassay of specific pyrolysis products anhydroecgonine methyl ester and ecgonidine; hybridomas; immunogens to evoke immune response in animals exposed to the metabolites; animal models |
| 09/12/2006 | US7105642 Monoclonal antibodies specific for phosphorylated estrogen receptor alpha (Ser118) and uses thereof |
| 09/12/2006 | US7105641 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents |
| 09/12/2006 | US7105634 Genetic constructs encoding carotenoid biosynthetic enzymes |
| 09/12/2006 | US7105580 Porous structures useful for growing living tissue, and methods of manufacture |
| 09/12/2006 | US7105484 GDNF receptorα |
| 09/12/2006 | US7105349 Selective plant growth using d-amino acids |
| 09/12/2006 | US7105347 Using surface-mediated protein transfected cell microarrays to screen polypeptide and enzyme activities; high throughput assay; drug screening |
| 09/12/2006 | US7105346 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 09/12/2006 | US7105345 Useful for gene delivery |
| 09/12/2006 | US7105344 Fluorescent proteins as cell-type specific reporters |
| 09/12/2006 | US7105342 In vitro proliferation of pluripotent neural stem cell; obtain mammalian neural tissues, dissociate neural tissue into suspension, culture, passaging neural stem cell progeny to a second culture and propagate cells |
| 09/12/2006 | US7105333 Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon |
| 09/12/2006 | US7105331 ICE/CED-3 like protease designated FMH-1 |
| 09/12/2006 | US7105330 Immunoglobulin for detection and isolation of preferential glycosidase; tumor diagnosis and antitumor agents |
| 09/12/2006 | US7105326 Generation of para-hydroxycinnamic acid; provide genetically engineered microorganism coding preferential lyases and oxidoreductases, propagate microorganism in presence of fermentable substrate, recover para-hydroxycinnamic |
| 09/12/2006 | US7105317 Immunogenic compositions comprising vrg-gene products from Bordetella extracts |